Prothena Corp Plc (NASDAQ: PRTA) has reported E.P.S. of $-1.08 for its fourth fiscal quarter (ending December 31) versus $-1.26 for the same period a year ago — a decline of -14%. E.P.S. were $-2.27 for the latest four quarters through December 31 versus $-2.76 for the same period a year ago — a decline of -18%.
Recent Price Action
On 2/20/25, Prothena Corp Plc (NASDAQ: PRTA) stock increased 1.8%, closing at $15.25. However, below average trading volume at 69% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 10.6% during the last week.
Current PriceTarget Research Rating
Prothena has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Prothena has a neutral Appreciation Score of 53 but a poor Power Rating of 19, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment